Glutamate plays an especially important role in clinical neurology because elevated concentrations of extracellular glutamate, released as a result of neural injury, are toxic to neurons. Free glutamic acid cannot cross the blood-brain barrier in the needed quantities but is instead converted into L-glutamine. The brain uses L-glutamine for fuel and protein synthesis. Glutamate is involved in cognitive functions like learning and memory in the brain. The neurotransmitter L-glutamate functions as an excitatory neurotransmitter and is a precursor for the synthesis of gamma-aminobutyric acid or γ-aminobutyric acid (GABA) in GABAergic neurons. GABAergic neurons transmit or secret γ-aminobutyric acid. L-Glutamate is also considered to be nature's "Brain food." L-glutamate helps to improve the mental capacities in humans and to speed up the healing of ulcers. In addition, L-glutamate has been reported to help control alcoholism, schizophrenia and the craving for sugar. However, excessive amounts of L-glutamate may cause neuronal damage and are associated with diseases such as amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. Glutamate activates both ionotropic and metabotropic glutamate receptors. Ionotropic and metabotropic receptors are both ligand gated transmembrane proteins. Ionotropic receptors change shape when they are bound by a ligand. This change in shape creates a channel that allows ions to flow through. On the other hand, metabotropic receptors do not have channels and activate a G-protein that in turn activates a secondary messenger that may then activate a "secondary effector" whose effects depend on the particular secondary messenger system.
Glutamate can cause neuronal damage and eventual cell death, particularly when N-Methyl-D-aspartic acid or N-Methyl-D-aspartate (NMDA) receptors are activated. High dosages of glutamic acid may induce symptoms such as headaches and neurological problems. The pathological process called excitotoxicity damages and kills nerve cells. This is caused via excessive stimulation by neurotransmitters such as glutamate and similar substances. Unfortunately, glutamate is of transient nature in biological systems and is therefore extremely difficult to study in action. However, quantitative amino acid analysis can be used to determine the presence of L-glutamate in different tissue types, plasma and other bodily fluids including dietary supplements and foods.
References:
- Augustin H, Grosjean Y, Chen K, Sheng Q, Featherstone DE: Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo. J Neurosci. 2007 Jan 3; 27(1):111-23.
- Burrin DG, Janeczko MJ, Stoll B.; Emerging aspects of dietary glutamate metabolism in the developing gut. Asia Pac J Clin Nutr. 2008; 17 Suppl 1:368-71.
- Corrie JE, DeSantis A, Katayama Y, Khodakhah K, Messenger JB, Ogden DC, Trentham DR: Postsynaptic activation at the squid giant synapse by photolytic release of L-glutamate from a ‘caged’ L-glutamate. J Physiol. 1993 Jun; 465:1-8.
- D’Mello, J.P.F.; Amino Acids in Human Nutrition and Health. Stylus Pub Llc. ISBN-13: 9781845937980, ISBN-10: 1845937988
- Herrling, Paul L.; Excitatory Amino Acids, 1st Edition. Clinical Results with Antagonists. 29 Jan 1997, Academic Press. ISBN : 9780125468206, eBook ISBN : 9780080531342. Mar 2012. ISBN-13: 9781845937980. ISBN-10: 1845937988
- Journal of amino acids: http://www.ncbi.nlm.nih.gov/pmc/journals/1711/ , and, http://www.hindawi.com/journals/jaa/
- Okumoto S, Looger LL, Micheva KD, Reimer RJ, Smith SJ, Frommer WB: Detection of glutamate release from neurons by genetically encoded surface-displayed FRET nanosensors. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8740-5. Epub 2005 Jun 6.
- Reeds PJ, Burrin DG, Stoll B, Jahoor F: Intestinal glutamate metabolism. J Nutr. 2000 Apr;130(4S Suppl):978S-82S.
- Smith QR: Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr. 2000 Apr;130(4S Suppl):1016S-22S.